Preparation of a Klebsiella pneumoniae conjugate nanovaccine using glycol-engineered Escherichia coli

Preparation of a Klebsiella pneumoniae conjugate nanovaccine using glycol-engineered Escherichia coli

Abstract Background Engineered strains of Escherichia coli have been used to produce bioconjugate vaccines using Protein Glycan Coupling Technology (PGCT). Nanovaccines have also entered the vaccine development arena with advances in nanotechnology and have been significantly developed, but chassis...

Full description

Bibliographic Details
Main Authors: Yan Liu, Chao Pan, Kangfeng Wang, Yan Guo, YanGe Sun, Xiang Li, Peng Sun, Jun Wu, Hengliang Wang, Li Zhu
Format: Article
Language:English
Published: BMC 2023-05-01
Series:Microbial Cell Factories
Subjects:
Glycosyltransferase
Bioconjugate vaccine
Conjugate nanovaccine
Klebsiella pneumoniae
Bacterial chassis
Online Access:https://doi.org/10.1186/s12934-023-02099-x

Internet

https://doi.org/10.1186/s12934-023-02099-x

Similar Items